Celsius Therapeutics

Celsius Therapeutics combines single-cell RNA analysis technology originating from the Broad Institute with AI and machine-learning models and large-scale clinical sample collection to pursue innovative drug discovery. Building on a deep understanding of disease biology, it works on identifying new targets and developing precision medicine through patient stratification.